Wilmington, DE, Nov. 2, 2022 (GLOBE NEWSWIRE) - Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced its financial results for the third quarter of 2022. The Company will host an investor conference call and live webcast to discuss these results today at 8:00am ET. Read more
Press Releases
Enovis Investor Relations: https://ir.enovis.com/
Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, celebrated the opening of its state-of-the-art manufacturing facility in Austin, Texas, on September 27, 2022 with a ribbon cutting ceremony. The new, 40,000-square-foot ISO 9001-certified center complements an existing 40,000-square-foot manufacturing facility and will employ an additional 100 team members to... Read more
Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase its foot & ankle continuum of care portfolio at the American Orthopaedic Foot & Ankle Society® (AOFAS) annual meeting in Quebec City, Canada from September 14-17, 2022. Read more
WILMINGTON, Del., July 19, 2022 – Today, Enovis (NYSE: ENOV), an innovation-driven medical technology company, announced the commercial launch of ARVIS® (Augmented Reality Visualization and Information System) with over 200 cases successfully completed in the U.S. This FDA-cleared system is the only proprietary, real-time, hands-free augmented reality (AR) technology... Read more
WILMINGTON, DE, JULY 6, 2022 —Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it has acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance. Insight’s flagship solution, ARVIS®, is the only FDA-cleared augmented reality solution precisely engineered for the specific needs of... Read more
